Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 24.30
-0.20 (-0.82%)
At close: Aug 1, 2025
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 1.08 billion as of August 1, 2025. Its market cap has increased by 13.55% in one year.
Market Cap
1.08B
Enterprise Value
1.07B
Revenue
440.66M
Ranking
n/a
PE Ratio
14.03
Stock Price
24.30
Market Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 1.08B, an increase of 234.30%. That is a compound annual growth rate of 12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.08B | 2.53% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | 773.81M | 67.79% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.18B |
| Nordhealth AS | 3.04B |
| Photocure ASA | 1.68B |
| Omda AS | 1.04B |
| ArcticZymes Technologies ASA | 939.71M |
| Gentian Diagnostics ASA | 913.00M |
| Thor Medical ASA | 870.72M |
| Lytix Biopharma AS | 607.53M |